The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy.
作者： Suisui Song , Sonali Rudra , Michael D. Hasselle , Paige L. Dorn , Loren K. Mell
DOI: 10.1002/CNCR.27652
关键词: Surgery 、 Brachytherapy 、 Hazard ratio 、 Urology 、 Cervical cancer 、 Cervix 、 Chemoradiotherapy 、 Cumulative incidence 、 Confidence interval 、 Medicine 、 Incidence (epidemiology)
摘要: … 2012 American Cancer Society. Historically, locally advanced cervical carcinomas were treated … beam RT to the whole pelvis and a brachytherapy (BT) boost to the cervix. In 1999, the …
sci-hub.se 参考文章(20)
Bradley J. Monk, Chunqiao Tian, Peter G. Rose, Rachelle Lanciano, Which clinical/pathologic factors matter in the era of chemoradiation as treatment for locally advanced cervical carcinoma? Analysis of two Gynecologic Oncology Group (GOG) trials. Gynecologic Oncology. ,vol. 105, pp. 427- 433 ,(2007) , 10.1016/J.YGYNO.2006.12.027
Charles W. Whitney, William Sause, Brian N. Bundy, John H. Malfetano, Edward V. Hannigan, Wesley C. Fowler, Jr, Daniel L. Clarke-Pearson, Shu-Yuan Liao, Randomized Comparison of Fluorouracil Plus Cisplatin Versus Hydroxyurea as an Adjunct to Radiation Therapy in Stage IIB-IVA Carcinoma of the Cervix With Negative Para-Aortic Lymph Nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study Journal of Clinical Oncology. ,vol. 17, pp. 1339- 1348 ,(1999) , 10.1200/JCO.1999.17.5.1339
Shang-Wen Chen, Ji-An Liang, Shih-Neng Yang, Hui-Ling Ko, Fang-Jen Lin, The adverse effect of treatment prolongation in cervical cancer byhigh-dose-rate intracavitary brachytherapy Radiotherapy and Oncology. ,vol. 67, pp. 69- 76 ,(2003) , 10.1016/S0167-8140(02)00439-5
B Jones, R G Dale, The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy British Journal of Radiology. ,vol. 78, pp. 939- 944 ,(2005) , 10.1259/BJR/40226390
Elizabeth K. Nugent, Ashley S. Case, John T. Hoff, Israel Zighelboim, Lorri L. DeWitt, Kim Trinkhaus, David G. Mutch, Premal H. Thaker, L. Stewart Massad, Janet S. Rader, Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors. Gynecologic Oncology. ,vol. 116, pp. 438- 441 ,(2010) , 10.1016/J.YGYNO.2009.09.045
T. Schefter, K. Winter, J.S. Kwon, K. Stuhr, M. Rotman, B.P. Yaremko, W. Small, D. Gaffney, RTOG 0417: A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma International Journal of Radiation Oncology*Biology*Physics. ,vol. 78, pp. S395- ,(2010) , 10.1016/J.IJROBP.2010.07.932
Anthony Fyles, Thomas J. Keane, Michael Barton, Janis Simm, The Effect of Treatment Duration in the Local Control of Cervix Cancer Radiotherapy and Oncology. ,vol. 25, pp. 273- 279 ,(1992) , 10.1016/0167-8140(92)90247-R
Yasumasa Nishimura, Rationale for chemoradiotherapy International Journal of Clinical Oncology. ,vol. 9, pp. 414- 420 ,(2004) , 10.1007/S10147-004-0443-Z
J. Ian Geh, Simon J. Bond, Søren M. Bentzen, Robert Glynne-Jones, Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response. Radiotherapy and Oncology. ,vol. 78, pp. 236- 244 ,(2006) , 10.1016/J.RADONC.2006.01.009
I.L. ATAHAN, C. ONAL, E. OZYAR, F. YILIZ, U. SELEK, F. KOSE, Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. International Journal of Gynecological Cancer. ,vol. 17, pp. 833- 842 ,(2007) , 10.1111/J.1525-1438.2007.00895.X